Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shenzhen Kangtai Biological Products

1988 FOUNDED
PUBLIC STATUS
901-1000 EMPLOYEES
300601 STOCK SYMBOL
$5.48 SHARE PRICE (As of Thursday Closing)
Description

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Stock Exchange
SHE
Primary Office
  • Kefa Road 6, Science & Industry Park
  • Nanshan
  • Shenzhen
  • China

+86 0755 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shenzhen Kangtai Biological Products’s full profile, request a free trial.

Shenzhen Kangtai Biological Products Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.11 - $11.25 $3.52B $5.51 $0.11 6.89M 639M

Shenzhen Kangtai Biological Products Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 4,032,846 3,078,175
Revenue 285,443 171,824 82,864 72,095
EBITDA 85,968 44,032 22,004 20,515
Net Income 66,445 31,771 12,943 10,004
Total Assets 466,593 338,615 230,551 205,463
Total Debt 74,816 45,993 52,198 40,678
Public Fundamental Data provided by Morningstar, Inc. disclaimer